EPHA7
MOLECULAR TARGETEPH receptor A7
EPHA7 (EPH receptor A7) is targeted by 26 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting EPHA7
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | erlotinib | 5.55 | 256 |
| 2 | foretinib | 4.34 | 76 |
| 3 | vandetanib | 4.30 | 73 |
| 4 | doramapimod | 4.06 | 57 |
| 5 | quizartinib | 3.99 | 53 |
| 6 | canertinib | 3.53 | 33 |
| 7 | tae 684 | 3.43 | 30 |
| 8 | fedratinib | 3.40 | 29 |
| 9 | gilteritinib | 3.40 | 29 |
| 10 | linifanib | 3.33 | 27 |
| 11 | mln 8054 | 3.33 | 27 |
| 12 | jnj 7706621 | 3.09 | 21 |
| 13 | at 9283 | 3.09 | 21 |
| 14 | lestaurtinib | 3.04 | 20 |
| 15 | danusertib | 2.94 | 18 |
| 16 | r 406 | 2.83 | 16 |
| 17 | cediranib | 2.83 | 16 |
| 18 | kw 2449 | 2.64 | 13 |
| 19 | ast 487 | 2.56 | 12 |
| 20 | brivanib | 2.48 | 11 |
| 21 | bms 754807 | 2.30 | 9 |
| 22 | su 014813 | 2.20 | 8 |
| 23 | rebastinib | 2.20 | 8 |
| 24 | golvatinib | 2.20 | 8 |
| 25 | Sorafenib | 1.79 | 5 |
| 26 | Crizotinib | 0.69 | 1 |
About EPHA7 as a Drug Target
EPHA7 (EPH receptor A7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 26 compounds with documented EPHA7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
EPHA7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.